港股異動 | 周大福(1929.HK)五日累漲約17% 第二季度內地同店銷售增長達23.0%
格隆匯10月15日丨周大福(1929.HK)漲約5%,報17.24港元創近三個月新高,近五日累漲約17%,總市值1724億港元。周大福公佈,於截至2021年9月30日止三個月,中國內地以及香港及澳門的同店銷售維持令人鼓舞的增長勢頭。在穩定的消費氣氛支持下,內地於季內的同店銷售增長為23.0%。香港及澳門業務持續改善,同店銷售錄得57.7%的強勁增長,此乃受惠於本地消費需求平穩及低基數效應。季內香港的同店銷售增長為35.1%,而澳門則由於過境口岸重開後遊客消費帶動令同店銷售增長達到232.5%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.